Edwards Lifesciences (EW) Intangibles (2009 - 2026)

Edwards Lifesciences has reported Intangibles for 18 years, with the latest figure at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Intangibles rose 4.51% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 4.51% YoY), and the FY2025 full-year result was $1.1 billion, down 4.11% from the prior year.
• Intangibles for Q1 2026 stood at $1.2 billion, up from $1.1 billion in the prior quarter.
• The five-year high for Intangibles was $1.2 billion in Q1 2026, with the low at $266.5 million in Q3 2022.
• Average Intangibles over 5 years is $690.2 million, with a median of $446.8 million recorded in 2023.
• Year-over-year, Intangibles retreated 18.08% in 2022 and jumped 194.59% in 2024.
• Tracing EW's Intangibles over 5 years: stood at $285.2 million in 2022, then jumped by 40.04% to $399.4 million in 2023, then jumped by 194.59% to $1.2 billion in 2024, then slipped by 4.11% to $1.1 billion in 2025, then gained by 8.84% to $1.2 billion in 2026.
• The last three Intangibles figures came in at $1.2 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison